Nonpharmacological Therapies in Alzheimer’s Disease: A Systematic Review of Efficacy

Publisher： Karger

E-ISSN： 1421-9824|30|2|161-178

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.30, Iss.2, 2010-09, pp. : 161-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nonsteroidal Anti-Inflammatory Drugs for the Prevention of Alzheimer’s Disease: A Systematic Review

By  

Neuroepidemiology, Vol. 23, Iss. 4, 2004-07 ,pp. : 159-169

Karger

Access to resources Recommend Favorite

The Efficacy of Licensed-Indication Use of Donepezil and Memantine Monotherapies for Treating Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease: Systematic Review and Meta-Analysis

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-07 ,pp. : 212-227

Karger

Access to resources Recommend Favorite

Systematic Review and Meta-Analysis of Combination Therapy with Cholinesterase Inhibitors and Memantine in Alzheimer’s Disease and Other Dementias

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 2, Iss. 1, 2012-11 ,pp. : 546-572

Karger

Access to resources Recommend Favorite

Cognitive Impairment in Studies of 5HTTLPR and Psychosis in Alzheimer’s Disease: A Systematic Review

By  

Dementia and Geriatric Cognitive Disorders, Vol. 35, Iss. 3-4, 2013-02 ,pp. : 155-164

Karger

Access to resources Recommend Favorite

Safety and Tolerability of Donepezil, Rivastigmine and Galantamine for Patients with Alzheimer’s Disease: Systematic Review of the ‘Real-World’ Evidence

By  

Dementia and Geriatric Cognitive Disorders, Vol. 28, Iss. 5, 2009-11 ,pp. : 478-492

Karger

Access to resources Recommend Favorite